Modification of the Cardiac Renal Angina Index for Predicting Adverse Kidney Events After Pediatric Cardiac Surgery

Katherine F Melink1,2, Natalja L Stanski1, Emily Gorrell1

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati OH USA.

Insights

A modified cardiac renal angina index (cRAI) effectively predicts adverse kidney events in pediatric cardiac surgery patients. Integrating urine neutrophil gelatinase-associated lipocalin further enhances prediction accuracy for these critical outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Nephrology
  • Cardiovascular surgery

Background:

  • Pediatric cardiac surgery-associated acute kidney injury (AKI) is a significant clinical challenge with poor prognoses.
  • Early and accurate prediction of AKI in this vulnerable population remains difficult.
  • The modified cardiac renal angina index (cRAI) was developed to aid in risk stratification.

Purpose of the Study:

  • To evaluate the predictive performance of the modified cRAI for adverse renal events in pediatric patients post-cardiac surgery.
  • To determine if integrating urine neutrophil gelatinase-associated lipocalin (NGAL) improves the predictive accuracy of the cRAI.
  • To assess the clinical utility of cRAI in identifying high-risk patients for adverse outcomes.

Main Methods:

  • A prospective, 2-center observational study involving 476 children (0-18 years) undergoing cardiac surgery.
  • A modified cRAI nomogram was developed using multivariable logistic regression to predict a composite outcome (postoperative AKI or prolonged mechanical ventilation).
  • The predictive performance of the cRAI model was compared with a model incorporating urine NGAL.

Main Results:

  • The modified cRAI demonstrated strong predictive performance (AUC 0.82) for the composite adverse renal outcome.
  • Patients with a positive cRAI had significantly worse outcomes, including higher mortality and longer ICU stays.
  • Integration of urine NGAL improved predictive performance (AUC 0.84), with enhanced sensitivity and specificity.

Conclusions:

  • The modified cRAI is a robust tool for predicting adverse renal outcomes in pediatric cardiac surgery patients.
  • A negative cRAI effectively rules out the composite adverse outcome, aiding in patient management.
  • Urine NGAL integration enhances the predictive power of the cRAI, offering potential for improved risk stratification and clinical trial enrichment.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
74
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
508
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
155